Evidence map›Paper›PMID 35943018›Full record

ArticleArchives of Iranian medicine2022

Severity of Disease and COVID-19 Complications During Hospital Stay: A Prospective Cohort Study.

Ramin Sami, Forogh Soltaninejad, Azin Shayganfar, Sam Mirfendereski, Marjan Mansourian, Nilufar Khademi, Mehrnegar Dehghan, Zahra Khorrami, Soheila Jalali, Zeinab Mokhtari

Open access · hybridAbstract read
In one paragraph

Article in Archives of Iranian medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Post-discharge health assessment in survivors of coronavirus disease: a time-point analysis of a prospective cohort study.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2023
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Ramin SamiDepartment of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.ORCID 0000-0002-7521-4631
Forogh SoltaninejadDepartment of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.ORCID 0000-0002-1773-7944
Azin ShayganfarDepartment of Radiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.ORCID 0000-0001-9367-268X
Sam MirfendereskiDepartment of Radiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.ORCID 0000-0002-6153-5696
Marjan MansourianBiostatistics, Pediatric Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.ORCID 0000-0002-7217-0282
Nilufar KhademiSchool of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.ORCID 0000-0002-2242-8775
Mehrnegar DehghanSchool of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.ORCID 0000-0002-6313-575X
Zahra KhorramiOphthalmic Epidemiology Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Soheila JalaliDepartment of Epidemiology and Biostatistics, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran.
Zeinab MokhtariFood Security Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.ORCID 0000-0001-9485-9454
Isfahan University of Medical Sciences · IRShahid Beheshti University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCOVID-19, with its high transmission and mortality rates and unknown outcomes, has become a major concern in the world. Among people with COVID-19, severe cases can quickly progress to serious complications, and even death. So, the present study aimed to examine the relationship between the severity of the disease and the outcome in patients afflicted by COVID-19 during hospitalization.

methodsA total of 653 patients with COVID-19 aged 18 years or older were included from Khorshid hospital in Isfahan, Iran and followed for a mean of 22.72 days (median 23.50; range 1-47). Severe COVID-19 was defined by respiration rate≥30 times/min, oxygen saturation level≤88% in the resting position, and pulse rate≥130/min. The primary outcome was mortality. The secondary outcomes included need for mechanical ventilation and intensive care unit (ICU) admission.

resultsDuring 4233 person-days of follow-up, 49 (7.5%) deaths, 27 (4.1%) invasive ventilation and 89 (13.6%) ICU admissions in hospital were reported. After adjustment for potential confounders, severity of the disease was positively associated with risk of mortality, invasive ventilation and ICU admissions (hazard ratio [HR]: 5.99; 95% CI: 2.85, 12.59;

conclusionMore intensive therapy and special monitoring should be implemented for patients with older age, hypertension and kidney disease who are infected with COVID-19 to prevent rapid worsening.

Indexed as

COVID-19HospitalizationHumansIntensive Care UnitsLength of StayProspective StudiesRespiration, ArtificialRisk FactorsSARS-CoV-2Severity of Illness IndexCOVID-19ICU admissionMortalitySARS-CoV-2Severity

Identifiers

PMID35943018
PMCPMC11904273
OpenAlexW4285101632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.